|
Glial Cell Line-Derived Neurotrophic Factor Receptors
|
D051097 |
[A family of GLYCOSYLPHOSPHATIDYLINOSITOL-anchored cell surface receptors that are specific for GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTORS. They form a multi-component receptor complex with PROTO-ONCOGENE PROTEIN C-RET and regulate a variety of intracellular SIGNAL TRANSDUCTION PATHWAYS in conjunction with c-ret protein.
] |
|
Glial Cell Line-Derived Neurotrophic Factors
|
D051098 |
[A family of closely related nerve growth factors that promote NEURON survival. They bind to GDNF RECEPTORS and stimulate SIGNAL TRANSDUCTION through PROTO-ONCOGENE PROTEIN C-RET.
] |
|
Ichthyosis, X-Linked
|
C16.320.322.241 |
|
|
Tarsii
|
D051099 |
[An infraorder (or suborder) of small PRIMATES comprised of a single family and genus.
] |
|
Petunia
|
B01.650.940.800.575.912.250.908.500.448 |
|
|
Glycogen Storage Disease Type IV
|
C18.452.648.202.449.540 |
|
|
Neurocytoma
|
C10.228.140.211.692 |
|
|
Bird Fancier's Lung
|
C08.381.483.125.125 |
|
|
Immunosenescence
|
G12.460.500 |
|
|
Tay-Sachs Disease
|
C16.320.565.398.641.803.350.300.850 |
|
|
Safflower Oil
|
J02.500.375.400.700 |
|
|
Wisteria
|
B01.650.940.800.575.912.250.401.984 |
|
|
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
|
D13.570.685.245.500.600.250 |
|
|
Emtricitabine
|
D13.570.685.245.500.600 |
|
|
Strontium
|
D01.552.544.825 |
|
|
Laryngeal Mucosa
|
A04.329.597 |
|
|
Hemophilia B
|
C16.320.322.235 |
|
|
Granulomatous Disease, Chronic
|
C16.320.322.233 |
|
|
Infarction, Posterior Cerebral Artery
|
C14.907.253.855.200.200.475 |
|
|
Stomach Rupture
|
C26.017.809 |
|
